Search Results - "Malta, Fernanda de Mello"
-
1
Mass molecular testing for COVID19 using NGS-based technology and a highly scalable workflow
Published in Scientific reports (29-03-2021)“…Since the first reported case of the new coronavirus infection in Wuhan, China, researchers and governments have witnessed an unseen rise in the number of…”
Get full text
Journal Article -
2
Evidence of reassortment of avian influenza A (H2) viruses in Brazilian shorebirds
Published in PloS one (13-05-2024)“…Influenza A viruses of the H2 subtype represent a zoonotic and pandemic threat to humans due to a lack of widespread specific immunity. Although A(H2) viruses…”
Get full text
Journal Article -
3
Nucleocapsid single point-mutation associated with drop-out on RT-PCR assay for SARS-CoV-2 detection
Published in BMC infectious diseases (23-10-2023)“…Since its beginning, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been a challenge for clinical and molecular diagnostics,…”
Get full text
Journal Article -
4
Sabiá Virus-Like Mammarenavirus in Patient with Fatal Hemorrhagic Fever, Brazil, 2020
Published in Emerging infectious diseases (01-06-2020)“…New World arenaviruses can cause chronic infection in rodents and hemorrhagic fever in humans. We identified a Sabiá virus-like mammarenavirus in a patient…”
Get full text
Journal Article -
5
Updating the Phylodynamics of Yellow Fever Virus 2016-2019 Brazilian Outbreak With New 2018 and 2019 São Paulo Genomes
Published in Frontiers in microbiology (14-04-2022)“…The recent outbreak of yellow fever (YF) in São Paulo during 2016-2019 has been one of the most severe in the last decades, spreading to areas with low vaccine…”
Get full text
Journal Article -
6
NAFLD in Polycystic Ovary Syndrome: Association with PNPLA3 and Metabolic Features
Published in Biomedicines (27-10-2022)“…Background: The aim of this study was to determine the frequency of the rs738409 polymorphism in the patatin-like phospholipase domain containing 3 (PNPLA3)…”
Get full text
Journal Article -
7
Prevalence and Pattern of Resistance in NS5A/NS5B in Hepatitis C Chronic Patients Genotype 3 Examined at a Public Health Laboratory in the State of São Paulo, Brazil
Published in Infection and drug resistance (01-01-2021)“…Globally, it is estimated that 71 million people are chronically infected with hepatitis C, and 10-20% of these will develop cirrhosis and hepatocellular…”
Get full text
Journal Article -
8
Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy
Published in World journal of gastroenterology : WJG (07-12-2006)“…AIM: TO evaluate the impact of hepatitis C virus (HCV) infection with genotype 1 or 3 and the presence or absence of liver cirrhosis (LC) in the early viral…”
Get full text
Journal Article -
9
Distribution of HBV subgenotypes in Ribeirão Preto, Southeastern Brazil: a region with history of intense Italian immigration
Published in The Brazilian journal of infectious diseases (01-07-2017)“…Hepatitis B virus (HBV) is distributed worldwide, with geographical variations regarding prevalence of the different genotypes. The aim of this study was to…”
Get full text
Journal Article -
10
Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up
Published in Revista de saúde pública (01-01-2017)“…To investigate the HCV cascade of care and to identify the factors associated with loss or absence to follow-up of patients identified as infected with…”
Get full text
Journal Article -
11
Resistance-associated variants in HCV subtypes 1a and 1b detected by Ion Torrent sequencing platform
Published in Antiviral therapy (01-01-2016)“…As a result of increased understanding of the HCV life cycle, a new generation of drugs known as direct-acting antivirals (DAAs) was developed and is…”
Get more information
Journal Article -
12
Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
Published in Infection and drug resistance (01-01-2018)“…Direct-acting antiviral agents (DAAs) permit the use of interferon (IFN)-free regimens to treat hepatitis C (HCV) in patients with chronic kidney disease (CKD)…”
Get full text
Journal Article -
13
SARS-CoV-2 isolation from the first reported patients in Brazil and establishment of a coordinated task network
Published in Memórias do Instituto Oswaldo Cruz (01-01-2020)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed in Brazil in February 2020, the first cases were followed by an increase in the…”
Get full text
Journal Article -
14
Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021
Published in Clinical infectious diseases (08-02-2023)“…Abstract Background Little is currently known about vaccine effectiveness (VE) for either 2 doses of Oxford-AstraZeneca (ChAdOx1) viral vector vaccine or…”
Get full text
Journal Article -
15
Metagenomic next-generation sequencing in patients with fever of unknown origin: A comprehensive systematic literature review and meta-analysis
Published in Diagnostic microbiology and infectious disease (01-10-2024)“…•mNGS shows promise in diagnosing fever of unknown origin (FUO).•Nine studies reviewed; mNGS positive rates from 66.7% to 93.5%.•Pooled sensitivity for mNGS:…”
Get full text
Journal Article -
16
Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020–2022
Published in Infection control and hospital epidemiology (01-12-2023)“…To determine risk factors for the development of long coronavirus disease 2019 (COVID-19) in healthcare personnel (HCP). We conducted a case-control study…”
Get full text
Journal Article -
17
Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers
Published in Infection control and hospital epidemiology (01-01-2023)“…We investigated real-world vaccine effectiveness for Oxford-AstraZeneca (ChAdOx1) and CoronaVac against laboratory-confirmed severe acute respiratory…”
Get full text
Journal Article -
18
Neutralizing antibody response after immunization with a COVID‐19 bivalent vaccine: Insights to the future
Published in Journal of medical virology (01-02-2024)“…The raising of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variants led to the use of COVID‐19 bivalent vaccines, which include antigens of…”
Get full text
Journal Article -
19
Liver Transplantation for Fulminant Hepatitis Attributed to Yellow Fever
Published in Hepatology (Baltimore, Md.) (01-03-2019)Get full text
Journal Article -
20
Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure
Published in Annals of hepatology (01-11-2019)“…Direct antiviral agents (DAAs) are very efficient in inhibiting hepatitis C virus and might be used to treat infections caused by other flaviviruses whose…”
Get full text
Journal Article